Together these data suggest that PNPLA3 I148M targeting and accumulation on LDs is required for initiating steatosis and further support a model by which PNPLA3 I148M sequesters ABHD5 and prevents activation of PNPLA2. The gene discussed is PNPLA2; the disease is steatosis.